Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease

scientific article published on 09 February 2012

Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.CROHNS.2012.01.017
P698PubMed publication ID22398075

P2093author name stringZuzana Zelinkova
Rob de Man
Antonie van Tilburg
Chiara van Casteren-Messidoro
Gerrie Prins
Joeffrey Schouten
P433issue5
P921main subjectautoimmune hepatitisQ786844
inflammatory bowel diseasesQ917447
P304page(s)630-631
P577publication date2012-02-09
P1433published inJournal of Crohn's and ColitisQ15817379
P1476titleAutoimmune hepatitis following treatment with infliximab for inflammatory bowel disease
P478volume6

Reverse relations

cites work (P2860)
Q64254899Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab
Q86886381Autoimmune hepatitis
Q35783976Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases
Q28087726Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics
Q97529168Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis
Q38496932Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease
Q48140916Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literature
Q36576535Hepatotoxicity Associated with the Use of Anti-TNF-α Agents
Q37607111Novel Immunotherapies for Autoimmune Hepatitis.
Q60953544Role of Biologics in the Development of Autoimmune Hepatitis: A Review

Search more.